KPV (Lysine-Proline-Valine)

KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide derived from the C-terminal region of alpha-melanocyte stimulating hormone (α-MSH). This research-grade peptide represents the minimal active sequence responsible for α-MSH's potent anti-inflammatory properties, acting through receptor-independent mechanisms distinct from melanocortin receptor signaling. KPV is utilized in laboratory research to study anti-inflammatory pathways, immune modulation, and antimicrobial mechanisms. All discussion herein is limited to experimental research contexts and does not imply applied, therapeutic, or physiological use.

KPV is employed in laboratory research to study anti-inflammatory mechanisms and immune regulation. Common experimental applications include NF-κB activation assays, cytokine production studies, and inflammatory response models in intestinal and skin tissues. Research protocols utilize KPV to investigate the relationship between α-MSH-derived peptides and inflammation control, particularly the receptor-independent pathways that may offer advantages for targeted anti-inflammatory approaches.

Mechanistically, KPV inhibits inflammation primarily through blocking NF-κB nuclear translocation. The peptide prevents IκB degradation, thereby trapping NF-κB in the cytoplasm and preventing transcription of pro-inflammatory genes including TNF-α, IL-1β, IL-6, and COX-2. Unlike full-length α-MSH, KPV does not significantly activate melanocortin receptors (MC1R-MC5R), enabling selective anti-inflammatory effects without melanogenesis or other melanocortin-mediated responses. This selectivity makes KPV valuable for studying NF-κB-specific anti-inflammatory mechanisms.

Preclinical investigations of KPV include in-vitro immune cell studies and in-vivo animal models evaluating inflammatory conditions. Reported findings include reduced cytokine production, decreased inflammatory cell infiltration, and improved outcomes in colitis and skin inflammation models. Animal studies explore effects on gastrointestinal inflammation, demonstrating protection in experimental colitis models. All findings are interpreted strictly within the context of laboratory research models.